Cachexia: clinical features when inflammation drives malnutrition
- 26 March 2015
- journal article
- review article
- Published by Cambridge University Press (CUP) in Proceedings of the Nutrition Society
- Vol. 74 (4) , 348-354
Abstract
Cachexia is a clinically relevant syndrome which impacts on quality of life, morbidity and mortality of patients suffering from acute and chronic diseases. The hallmark of cachexia is muscle loss, which is triggered by disease-associated inflammatory response. Cachexia is a continuum and therefore a staging system is needed. Initially, a three-stage system (i.e. pre-cachexia, cachexia and refractory cachexia) was proposed. More recent evidence supports the use of a five-stage classification system, based on patient's BMI and severity of weight loss, to better predict clinical outcome. Also, large clinical trials in cancer patients demonstrated that cachexia emerging during chemotherapy has greater influence on survival than weight loss at baseline. Therefore, becoming widely accepted is the importance of routinely monitoring patients’ nutritional status to detect early changes and diagnose cachexia in its early phases. Although cachexia is associated with the presence of anabolic resistance, it has been shown that sustained yet physiological hyperaminoacidaemia, as well as the use of specific nutrients, is able to overcome impaired protein synthesis and revert catabolism. More importantly, clinical evidence demonstrates that preservation of nutritional status during chemotherapy or improvement of body weight after weight loss is associated with longer survival in cancer patients.Keywords
This publication has 35 references indexed in Scilit:
- Cancer cachexia: understanding the molecular basisNature Reviews Cancer, 2014
- Muscle wasting: An overview of recent developments in basic researchInternational Journal of Cardiology, 2014
- Central tenet of cancer cachexia therapy: do patients with advanced cancer have exploitable anabolic potential?The American Journal of Clinical Nutrition, 2013
- Sarcopenia and body mass index predict sunitinib-induced early dose-limiting toxicities in renal cancer patientsBritish Journal of Cancer, 2013
- Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgeryBritish Journal of Cancer, 2012
- Role and potential mechanisms of anabolic resistance in sarcopeniaJournal of Cachexia, Sarcopenia and Muscle, 2012
- Muscle protein synthesis in cancer patients can be stimulated with a specially formulated medical foodClinical Nutrition, 2011
- Intensive care unit—acquired weakness (ICUAW) and muscle wasting in critically ill patients with severe sepsis and septic shockJournal of Cachexia, Sarcopenia and Muscle, 2010
- Cachexia: A new definitionClinical Nutrition, 2008
- Neural control of the anorexia-cachexia syndromeAmerican Journal of Physiology-Endocrinology and Metabolism, 2008